EUVIMEDEUVIMED entdecken
Crossref

Daidzein ameliorates doxorubicin-induced cardiac injury by inhibiting autophagy and apoptosis in rats

Jinxia Wu, Kexue Li, Yan Liu, Ailu Feng, Chunyang Liu, Joseph Adu-Amankwaah, Miaojin Ji, Yanhong Ma, Yanling Hao, Huimin Bu, Hong Sun

Food & Function · 2023 · 14 (2) · 934-945

DOI: 10.1039/d2fo03416f ↗

Kurz gefasst

Fachartikel in der Zeitschrift Food & Function, 2023. Verfasst von Jinxia Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Xuzhou Medical University, Xuzhou 221004, Jiangsu, China. sunh@xzhmu.edu.cn. Hauptthemen laut MEDLINE: Cyclin D1, Isoflavones. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Jiangsu Planned Projects for Postdoctoral Research Funds, China Postdoctoral Science Foundation, Natural Science Research of Jiangsu Higher Education Institutions of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Doxorubicin (Dox) is a classical antitumor antibiotic widely restricted for use due to its cardiotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclin D1IsoflavonesRatsMaleAnimalsCardiotoxicityProto-Oncogene Proteins c-aktRats, Sprague-Dawleybcl-2-Associated X ProteinPhosphatidylinositol 3-KinasesSignal TransductionCell LineDoxorubicinMyocytes, CardiacApoptosisAutophagyProto-Oncogene Proteins c-bcl-2Oxidative Stress

Substanzen

daidzeinCyclin D1Proto-Oncogene Proteins c-aktbcl-2-Associated X ProteinPhosphatidylinositol 3-KinasesDoxorubicinIsoflavonesProto-Oncogene Proteins c-bcl-2

Autor:innen und Institutionen

  • Department of Physiology, Xuzhou Medical University, Xuzhou 221004, Jiangsu, China. sunh@xzhmu.edu.cn.
  • Jiangsu Province Key Laboratory of Anesthesiology and Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, School of Anesthesiology, Xuzhou Medical University, Xuzhou 221004, Jiangsu, Chin…

Förderung

  • Jiangsu Planned Projects for Postdoctoral Research Funds
  • China Postdoctoral Science Foundation
  • Natural Science Research of Jiangsu Higher Education Institutions of China
  • National Natural Science Foundation of China

Zitieren

APA

Wu, J., Li, K., Liu, Y., Feng, A., Liu, C., Adu-Amankwaah, J., Ji, M., Ma, Y., Hao, Y., Bu, H., & Sun, H. (2023). Daidzein ameliorates doxorubicin-induced cardiac injury by inhibiting autophagy and apoptosis in rats. Food & Function, 14(2), 934-945. https://doi.org/10.1039/d2fo03416f

Vancouver

Wu J, Li K, Liu Y, Feng A, Liu C, Adu-Amankwaah J, et al. Daidzein ameliorates doxorubicin-induced cardiac injury by inhibiting autophagy and apoptosis in rats. Food & Function. 2023;14(2):934-945. doi:10.1039/d2fo03416f

BibTeX
@article{Wu2023,
  author = {Wu, Jinxia and Li, Kexue and Liu, Yan and Feng, Ailu and Liu, Chunyang and Adu-Amankwaah, Joseph and Ji, Miaojin and Ma, Yanhong and Hao, Yanling and Bu, Huimin and Sun, Hong},
  title = {Daidzein ameliorates doxorubicin-induced cardiac injury by inhibiting autophagy and apoptosis in rats},
  journal = {Food & Function},
  year = {2023},
  volume = {14},
  number = {2},
  pages = {934--945},
  doi = {10.1039/d2fo03416f}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche